Cargando…
A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns
BACKGROUND: Active tuberculosis (TB) case finding is important as it helps detect pulmonary TB cases missed by the other active screening methods. It requires periodic mass screening in risk population groups such as prisoners and refugees. Unfortunately, in these risk population groups periodic mas...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895851/ https://www.ncbi.nlm.nih.gov/pubmed/35246071 http://dx.doi.org/10.1186/s12879-022-07157-0 |
_version_ | 1784663018637885440 |
---|---|
author | Donkeng-Donfack, Valerie Flore Tchatchueng-Mbougua, Jules Brice Abanda, Ngu Njei Ongboulal, Suzanne Magloire Djieugoue, Yvonne Josiane Kamdem Simo, Yannick Mekemnang Tchoupa, Micheline Bekang Angui, Frédéric Kuate Kuate, Albert Mbassa, Vincent Mvondo Abeng Belinga, Edwige Eyangoh, Sara |
author_facet | Donkeng-Donfack, Valerie Flore Tchatchueng-Mbougua, Jules Brice Abanda, Ngu Njei Ongboulal, Suzanne Magloire Djieugoue, Yvonne Josiane Kamdem Simo, Yannick Mekemnang Tchoupa, Micheline Bekang Angui, Frédéric Kuate Kuate, Albert Mbassa, Vincent Mvondo Abeng Belinga, Edwige Eyangoh, Sara |
author_sort | Donkeng-Donfack, Valerie Flore |
collection | PubMed |
description | BACKGROUND: Active tuberculosis (TB) case finding is important as it helps detect pulmonary TB cases missed by the other active screening methods. It requires periodic mass screening in risk population groups such as prisoners and refugees. Unfortunately, in these risk population groups periodic mass screening can be challenging due to lengthy turnaround time (TAT), cost and implementation constraints. The aim of this study was to evaluate a diagnostic algorithm that can reduce the TAT and cost for TB and Rifampicin resistance (RR) detection. The algorithm involves testing with TB-LAMP followed by Xpert MTB/RIF for positive TB-LAMP cases to diagnose TB during mass campaigns in prisons and refugee camps. METHODS: The National Tuberculosis Control Program (NTCP) organized routine TB mass-screening campaigns in 34 prisons and 3 villages with refugees camps in Cameroon in 2019. TB LAMP was used for initial TB diagnosis and all TB-LAMP positive cases tested with the Xpert MTB/RIF assay to determine RR. TAT and cost benefits analysis of the combined use of TB-LAMP and Xpert MTB/RIF assays was determined and compared to the Xpert MTB/RIF assay when used only. RESULTS: A total of 4075 sputum samples were collected from TB presumptive, 3672 cases in 34 prisons and 403 samples in 3 villages. Of the 4,075 samples screened with TB-LAMP, 135 were TB positive (3.31%) and run on the Xpert MTB/RIF. Of the 135 positives cases, Xpert MTB/RIF revealed 3 were RR (2.22%). The use of TB-LAMP followed by testing with Xpert MTB/RIF for TB and RR detection reduced the TAT by 73.23% in prisons and 74.92% in villages. In addition to a reduced TAT, the two molecular tests used in synergy is cost benefit from year 2 onwards. CONCLUSION: This study demonstrates the advantages of a diagnostic algorithm based on an initial testing with TB-LAMP followed by testing with Xpert MTB/RIF for TB diagnosis. This approach improved early and rapid TB detection with an added advantage of providing RR status. The proposed algorithm is effective and less costly from the second year of implementation and should be used by TB control programs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07157-0. |
format | Online Article Text |
id | pubmed-8895851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88958512022-03-10 A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns Donkeng-Donfack, Valerie Flore Tchatchueng-Mbougua, Jules Brice Abanda, Ngu Njei Ongboulal, Suzanne Magloire Djieugoue, Yvonne Josiane Kamdem Simo, Yannick Mekemnang Tchoupa, Micheline Bekang Angui, Frédéric Kuate Kuate, Albert Mbassa, Vincent Mvondo Abeng Belinga, Edwige Eyangoh, Sara BMC Infect Dis Technical Advance BACKGROUND: Active tuberculosis (TB) case finding is important as it helps detect pulmonary TB cases missed by the other active screening methods. It requires periodic mass screening in risk population groups such as prisoners and refugees. Unfortunately, in these risk population groups periodic mass screening can be challenging due to lengthy turnaround time (TAT), cost and implementation constraints. The aim of this study was to evaluate a diagnostic algorithm that can reduce the TAT and cost for TB and Rifampicin resistance (RR) detection. The algorithm involves testing with TB-LAMP followed by Xpert MTB/RIF for positive TB-LAMP cases to diagnose TB during mass campaigns in prisons and refugee camps. METHODS: The National Tuberculosis Control Program (NTCP) organized routine TB mass-screening campaigns in 34 prisons and 3 villages with refugees camps in Cameroon in 2019. TB LAMP was used for initial TB diagnosis and all TB-LAMP positive cases tested with the Xpert MTB/RIF assay to determine RR. TAT and cost benefits analysis of the combined use of TB-LAMP and Xpert MTB/RIF assays was determined and compared to the Xpert MTB/RIF assay when used only. RESULTS: A total of 4075 sputum samples were collected from TB presumptive, 3672 cases in 34 prisons and 403 samples in 3 villages. Of the 4,075 samples screened with TB-LAMP, 135 were TB positive (3.31%) and run on the Xpert MTB/RIF. Of the 135 positives cases, Xpert MTB/RIF revealed 3 were RR (2.22%). The use of TB-LAMP followed by testing with Xpert MTB/RIF for TB and RR detection reduced the TAT by 73.23% in prisons and 74.92% in villages. In addition to a reduced TAT, the two molecular tests used in synergy is cost benefit from year 2 onwards. CONCLUSION: This study demonstrates the advantages of a diagnostic algorithm based on an initial testing with TB-LAMP followed by testing with Xpert MTB/RIF for TB diagnosis. This approach improved early and rapid TB detection with an added advantage of providing RR status. The proposed algorithm is effective and less costly from the second year of implementation and should be used by TB control programs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07157-0. BioMed Central 2022-03-04 /pmc/articles/PMC8895851/ /pubmed/35246071 http://dx.doi.org/10.1186/s12879-022-07157-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Technical Advance Donkeng-Donfack, Valerie Flore Tchatchueng-Mbougua, Jules Brice Abanda, Ngu Njei Ongboulal, Suzanne Magloire Djieugoue, Yvonne Josiane Kamdem Simo, Yannick Mekemnang Tchoupa, Micheline Bekang Angui, Frédéric Kuate Kuate, Albert Mbassa, Vincent Mvondo Abeng Belinga, Edwige Eyangoh, Sara A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns |
title | A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns |
title_full | A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns |
title_fullStr | A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns |
title_full_unstemmed | A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns |
title_short | A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns |
title_sort | cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns |
topic | Technical Advance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895851/ https://www.ncbi.nlm.nih.gov/pubmed/35246071 http://dx.doi.org/10.1186/s12879-022-07157-0 |
work_keys_str_mv | AT donkengdonfackvalerieflore acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT tchatchuengmbouguajulesbrice acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT abandangunjei acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT ongboulalsuzannemagloire acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT djieugoueyvonnejosiane acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT kamdemsimoyannick acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT mekemnangtchoupamicheline acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT bekanganguifrederic acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT kuatekuatealbert acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT mbassavincent acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT mvondoabengbelingaedwige acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT eyangohsara acostbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT donkengdonfackvalerieflore costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT tchatchuengmbouguajulesbrice costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT abandangunjei costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT ongboulalsuzannemagloire costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT djieugoueyvonnejosiane costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT kamdemsimoyannick costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT mekemnangtchoupamicheline costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT bekanganguifrederic costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT kuatekuatealbert costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT mbassavincent costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT mvondoabengbelingaedwige costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns AT eyangohsara costbenefitalgorithmforrapiddiagnosisoftuberculosisandrifampicinresistancedetectionduringmassscreeningcampaigns |